Vertex, Inc. (VERX)

Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference

Vertex to Announce Third Quarter 2026 Financial Results November 2nd

Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Vertex Appoints DataRobot CEO Debanjan Saha to Board of Directors

2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.

Corient Private Wealth LP Purchases 153,840 Shares of Vertex, Inc. $VERX

CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Vertex Posts Positive Phase II Data on Kidney Disease Drug

Vertex Touts Encouraging Data From 'Underappreciated' Kidney Drug

Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

AbbVie vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead

Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis

Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference

Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher

Vertex, Inc. (VERX) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript

Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech Stock

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

Vertex to Present at the Goldman Sachs Communacopia + Technology Conference